The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

A research centre specialising in the financial reforms introduced by Manmohan Singh would be established at Bangalore ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

At the CXO-Entrepreneurs Alumni Meet 2024, hosted by MIT World Peace University (MIT-WPU), thought leaders and ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

Biocon rallied 4.63% to Rs 344.80 after it received an establishment inspection report (EIR) with a voluntary action indicated (VAI) status from the US drug regulator, for API facility located at ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...